Literature DB >> 2903429

Value of flumazenil in benzodiazepine self-poisoning.

F Prischl1, A Donner, G Grimm, R Smetana, K Hruby.   

Abstract

The efficacy of the benzodiazepine-antagonist flumazenil (Ro 15-1788) was evaluated in 26 patients with coma due to benzodiazepine self poisoning, alone or in combination with alcohol or other psychoactive drugs. 77% of the patients responded to the administration of a mean dose of 1.73 mg (range 0.2 to 8 mg) with immediate awakening or an improvement of at least 2 coma grades. In the patients without response (n = 3) or with minor improvement (n = 3) other psychoactive drugs turned out to be predominantly responsible for their comatose state. Adverse effects of flumazenil treatment such as altered blood pressure or increased heart rate were observed, but were generally mild. An acute benzodiazepine withdrawal syndrome was seen in 2 cases. In conclusion, flumazenil proved to be effective in the treatment of severe benzodiazepine intoxication. Beyond that, in cases of mixed overdosage or initially unknown diagnosis the antidote assisted in the clarification of the clinical condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903429     DOI: 10.1007/bf03259944

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  15 in total

1.  Ro 15-1788 for postoperative recovery. A randomised clinical trial in patients undergoing minor surgical procedures under midazolam anaesthesia.

Authors:  J Wolff; P Carl; T G Clausen; B O Mikkelsen
Journal:  Anaesthesia       Date:  1986-10       Impact factor: 6.955

2.  Fatal intoxication due to flunitrazepam.

Authors:  B Heyndrickx
Journal:  J Anal Toxicol       Date:  1987 Nov-Dec       Impact factor: 3.367

3.  [Comparative clinical toxicology of 5 benzodiazepine derivatives].

Authors:  U Jäger; K Hruby; A Haubenstock; I Fasching
Journal:  Nervenarzt       Date:  1984-03       Impact factor: 1.214

4.  The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam.

Authors:  P M Lauven; H Schwilden; H Stoeckel; D J Greenblatt
Journal:  Anesthesiology       Date:  1985-07       Impact factor: 7.892

5.  Weaning patients from mechanical ventilation by benzodiazepine antagonist Ro15-1788.

Authors:  G Kleinberger; G Grimm; A Laggner; W Drume; K Lenz; B Schneeweiss
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

6.  Benzodiazepine overdose: are specific antagonists useful.

Authors:  C H Ashton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16

Review 7.  Drug therapy. Benzodiazepines (first of two parts).

Authors:  D J Greenblatt; R I Shader
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

8.  Benzodiazepine overdosage: plasma concentrations and clinical outcome.

Authors:  M Divoll; D J Greenblatt; Y Lacasse; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 9.  Flumazenil in benzodiazepine antagonism. Actions and clinical use in intoxications and anaesthesiology.

Authors:  R Amrein; B Leishman; C Bentzinger; G Roncari
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  3 in total

Review 1.  A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.

Authors:  A A Weinbroum; R Flaishon; P Sorkine; O Szold; V Rudick
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

2.  Flumazenil causing convulsions and ventricular tachycardia.

Authors:  B Marchant; R Wray; A Leach; M Nama
Journal:  BMJ       Date:  1989-09-30

Review 3.  The use of flumazenil in the management of acute drug poisoning--a review.

Authors:  A Weinbroum; P Halpern; E Geller
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.